Sleep disturbances in inflammatory bowel disease: mechanisms, clinical consequences, and therapeutic implications

Background. Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is commonly associated with sleep disturbances and fatigue. Sleep disruption interacts bidirectionally with immune and neuroendocrine pathways, affecting disease activity, relapse risk, and long-term outcomes. Aim. This review synthesizes current evidence on the relationship between sleep disturbances and IBD, focusing on pathophysiological mechanisms, clinical correlations, and prognostic and therapeutic implications. It evaluates whether sleep disorders are secondary to inflammation or independent contributors to disease progression, supporting the integration of sleep assessment into IBD care. Material and methods. A narrative review of studies published between 2000 and 2025 was conducted using PubMed and Scopus. Search terms included “inflammatory bowel disease”, “Crohn’s disease”, “ulcerative colitis”, “sleep”, “circadian rhythm”, “fatigue”, and “cytokines”. Included were clinical and preclinical studies, systematic reviews, and meta-analyses addressing sleep and inflammatory mechanisms in IBD. Selection was based on relevance and methodological quality. Results. Pro-inflammatory cytokines (IL-1, IL-6, TNF-α) regulate NREM sleep, while their chronic elevation in IBD contributes to sleep fragmentation and systemic inflammation. Sleep deprivation worsens intestinal barrier function via ER stress in goblet cells, increasing mucosal inflammation. Dysregulation of the HPA axis and leptin signaling further enhances immune activation. Poor sleep correlates with subclinical inflammation, higher relapse risk, fatigue, and long-term complications. Psychological comorbidities and pharmacotherapy additionally influence sleep quality. Conclusions. Sleep disturbances are common in IBD, mechanistically linked to its pathophysiology, and impact disease course. Routine sleep assessment and targeted interventions may improve quality of life and potentially modify outcomes.

Authors

Institutions

Publication Details

Journal
Quality in Sport
Published
2026-04-16
DOI
https://doi.org/10.12775/qs.2026.54.70411
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sleep disturbances in inflammatory bowel disease: mechanisms, clinical consequences, and therapeutic implications

Aleksandra Polanska, Kacper Paczosa, Małgorzata Jerczak, Filip Przybył et al.
Quality in Sport
Inflammatory Bowel Disease
article

Sleep disturbances in inflammatory bowel disease: mechanisms, clinical consequences, and therapeutic implications

Aleksandra Polanska, Kacper Paczosa, Małgorzata Jerczak, Filip Przybył, Iga Piórkowska, Tomasz Pluszyński, Mikołaj Polewka
article en

Abstract

Background. Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is commonly associated with sleep disturbances and fatigue. Sleep disruption interacts bidirectionally with immune and neuroendocrine pathways, affecting disease activity, relapse risk, and long-term outcomes. Aim. This review synthesizes current evidence on the relationship between sleep disturbances and IBD, focusing on pathophysiological mechanisms, clinical correlations, and prognostic and therapeutic implications. It evaluates whether sleep disorders are secondary to inflammation or independent contributors to disease progression, supporting the integration of sleep assessment into IBD care. Material and methods. A narrative review of studies published between 2000 and 2025 was conducted using PubMed and Scopus. Search terms included “inflammatory bowel disease”, “Crohn’s disease”, “ulcerative colitis”, “sleep”, “circadian rhythm”, “fatigue”, and “cytokines”. Included were clinical and preclinical studies, systematic reviews, and meta-analyses addressing sleep and inflammatory mechanisms in IBD. Selection was based on relevance and methodological quality. Results. Pro-inflammatory cytokines (IL-1, IL-6, TNF-α) regulate NREM sleep, while their chronic elevation in IBD contributes to sleep fragmentation and systemic inflammation. Sleep deprivation worsens intestinal barrier function via ER stress in goblet cells, increasing mucosal inflammation. Dysregulation of the HPA axis and leptin signaling further enhances immune activation. Poor sleep correlates with subclinical inflammation, higher relapse risk, fatigue, and long-term complications. Psychological comorbidities and pharmacotherapy additionally influence sleep quality. Conclusions. Sleep disturbances are common in IBD, mechanistically linked to its pathophysiology, and impact disease course. Routine sleep assessment and targeted interventions may improve quality of life and potentially modify outcomes.

Quality in SportVol. 54
Medical University of Silesia (PL)
Openalex Percentile: Top 21%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.